B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six-month, national, multicenter, open-label study-Reference-Cited by-同舟云学术

B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six-month, national, multicenter, open-label study

Published:2011-03-30 Issue:4 Volume:63 Page:933-938
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Sellam Jérémie,Hendel-Chavez Houria,Rouanet Stéphanie,Abbed Karim,Combe Bernard,Le Loët Xavier,Tebib Jacques,Sibilia Jean,Taoufik Yassine,Dougados Maxime,Mariette Xavier

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.30233/fullpdf

Reference25 articles.

1. In the clinic: rheumatoid arthritis;Huizinga;Ann Intern Med,2010

2. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks;Cohen;Arthritis Rheum,2006

3. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus;Eisenberg;Nat Clin Pract Rheumatol,2006

4. B cells in the pathogenesis and treatment of rheumatoid arthritis;Marston;Curr Opin Rheumatol,2010

5. Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy;Martinez-Gamboa;Autoimmun Rev,2006

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials;Rheumatology;2024-02-16

2. [68 Ga]Ga-FAPI-04 PET/CT may be a predictor for early treatment response in rheumatoid arthritis;EJNMMI Research;2024-01-04

3. B Cell–Directed Therapy in Autoimmunity;Annual Review of Immunology;2023-11-27

4. Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics;Rheumatology;2023-05-30

5. Benefits of Autoantibody Enrichment in Early Rheumatoid Arthritis: Analysis of Efficacy Outcomes in Four Pooled Abatacept Trials;Rheumatology and Therapy;2023-05-25